Fig. 8From: Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancerThe data showed a dramatic difference in DU-145-px459-sgRNA1, 2 compared with DU-145-px459 and blank control. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page